|Articles|October 14, 2020
- Pharmaceutical Executive-10-01-2020
- Volume 40
- Issue 10
Pharmaceutical Executive, October 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The SPAC Makes a Comeback!over 5 years ago
Leadership and Industry Imageover 5 years ago
The Interplay Between COVID-19 Pandemic and NCD Epidemicover 5 years ago
FDA Struggles to Retain Credibilityover 5 years ago
Critical Connection: Patient Services and Product Launchover 5 years ago
Mastering the Transition From Academia to Industryover 5 years ago
Smoothing Access Pathover 5 years ago
The COVID Boost to AI in Global Healthover 5 years ago
Speed and SensitivityAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report
2
AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS
3
Preparing for the July 31 Pharma Tariff Deadline
4
Realistic Timelines for Pharma Manufacturing Reshoring
5